UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000050426 |
|---|---|
| Receipt number | R000057426 |
| Scientific Title | Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab |
| Date of disclosure of the study information | 2023/02/25 |
| Last modified on | 2023/02/25 14:24:56 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab
Acronym
Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab
Scientific Title
Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab
Scientific Title:Acronym
Impact of liver fibrosis to Urease-positive Streptococcus salivarius group isolated from oral swab
Region
| Japan |
Condition
Condition
Chronic liver diseasea
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
we assessed a strain-resolved and integrated genomic analyses of saliva collected from patients with chronic liver disease
Basic objectives2
Others
Basic objectives -Others
we assessed the frequency and type of urease-positive S. salivarius group isolated from oral saliva by the genomic analyses
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
the correlation between the liver fibrosis and a urease-positive S. salivarius rate in patients with CLD was evaluated.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients were required to meet the following inclusion criteria: (1) the presence of chronic liver disease, (2) men and women over twenty years old.
Key exclusion criteria
none
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | hisashi |
| Middle name | |
| Last name | hidaka |
Organization
Kitasato University School of Medicine
Division name
Gastroenterology
Zip code
252-0375
Address
1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa
TEL
042-778-8111
hisashi7@kitasato-u.ac.jp
Public contact
Name of contact person
| 1st name | Haruki |
| Middle name | |
| Last name | Uojima |
Organization
Kitasato University School of Medicine
Division name
Gastroenterology
Zip code
2530082
Address
1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa
TEL
042-778-8111
Homepage URL
kiruha@kitasato-u.ac.jp
Sponsor or person
Institute
other
Institute
Department
Personal name
Funding Source
Organization
self
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
the Ethics Committee of Kitasato University Hospital
Address
1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa
Tel
042-778-8111
rinrib@med.kitasato-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 02 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2022 | Year | 04 | Month | 01 | Day |
Date of IRB
| 2022 | Year | 09 | Month | 01 | Day |
Anticipated trial start date
| 2022 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 01 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
none
Management information
Registered date
| 2023 | Year | 02 | Month | 25 | Day |
Last modified on
| 2023 | Year | 02 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057426
